Anticoagulant Drugs and Antiplatelets Flashcards

1
Q

what is haemostasis?

A

arrest of blood loss from damaged blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does haemostasis occur?

A
  • vascular constriction
  • formation of platelet plug
  • formation of blood clot as a result of coagulation
  • growth of fibrous tissue into clot to close hole permanently
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some causes of acquired clotting defects?

A
  • liver disease
  • vitamin k deficiency
  • ingestion of oral anti-coagulants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are acquired clotting defects treated?

A
  • natural vitamin k (phytomenadione)

- menadiol sodium phosphate (synthetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are clinical uses of vitamin k?

A
  • treatment and/or prevention of bleeding from excessive oral anticoagulant use
  • in babies to prevent haemorrhagic disease of newborn
  • vitamin k deficiency in adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are features of warfarin?

A
  • main oral anticoagulant in uk
  • prevents reduction of vitamin k
  • many hours to act (time taken for degradation of factors already formed)
  • main side effect haemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when does vitamin k acts as a co-factor?

A

in the post-translational processing of factors II, VII, IX and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what factors increase the effect of oral anticoagulants?

A
  • decreasing availability of vitamin k
  • broad spectrum antibiotics
  • liver disease
  • some drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what properties of drugs increase effect of oral anticoagulants?

A
  • impair platelet function
  • displace warfarin from binding sites in plasma albumin
  • agents which inhibit microsomal enzymes in liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what factors decrease the effect of oral anticoagulants?

A
  • drugs which increase drug metabolism

- oral contraceptive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are some injectable anticoagulants?

A
  • heparin (e.g dalteparin)

- heparin sulphate (not used therapeutically)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are features of heparin?

A
  • e.g. dalteparin
  • family of sulphated gylcosaminoglycans
  • naturally occurring
  • found in mast cells, plasma, endothelial cells
  • starts acting almost immediately
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are features of heparan sulphate

A
  • not used therapeutically
  • a related glycosaminoglycan
  • occurs extracellularly in many tissues
  • important endogenous anticoagulant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the role of heparin?

A

acts mainly on fibrin formation:

  • acts on antithrombin III (naturally occuring inhibitorof thrombin) and other serine proteases in coagulation cascade (XIIa, XIa, IXa and Xa)
  • antithrombin forms 1:1 complex by with thrombin by binding to active site
  • heparin accelerates rate of this inhibition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are direct inhibitors of factor Xa?

A

rivaroxaban or apixaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are features of direct factor Xa inhibitors?

A
  • both orally active
  • do not require PT/INR monitoring
  • takes a few hours to act
  • effects last 8-12 hours
  • no antidote
17
Q

what do antiplatelet drugs do?

A

decrease platelet aggregation and inhibit thrombus formation - not anticoagulants

18
Q

what are some examples of antiplatelets?

A
  • aspirin

- clopidogrel

19
Q

what is the action of aspirin?

A

inhibit cyclooxegenase

20
Q

what is the action of clopidogrel?

A
  • inhibits P2Y12 purinergic receptors

- inhibits ADP-induced platelet aggregation

21
Q

what is fibrinolysis?

A
  • clot dissolving system
  • set in motion when intrinsic coagulation system is activated
  • involves generation of plasminogen activators
22
Q

what is plasminogen?

A

inactive pro-enzyme

- deposited in fibrin strands within thrombus

23
Q

what is plasmin?

A
  • trypsin-like enzyme acting on ARG-LYS bonds

- formed and acts locally on fibrin meshwork of the clot

24
Q

what does plasmin do?

A
  • digests not only fibrin but other blood proteins such as factors II, V and VII
  • plasmin which escapes into circulation is inactivated by various plasmin inhibitors
25
Q

name a fibrinolytic agent?

A

streptokinase

26
Q

what are features of streptokinase?

A
  • non-enzymatic protein
  • acts indirectly
  • forms a stable complex with plasminogen
27
Q

what is an example of a TPA (tissue plasminogen activator)?

A

alteplase

28
Q

what are features of alteplase?

A
  • synthesised in vivo by endothelial cells
  • can be made by recombinant technology
  • enzymatic activity enhanced more in presence of fibrin-bound plasminogen than plasma plasminogen (clot selective)
29
Q

which anticoagulant is used for venous thromboembolism?

A

heparin: short-term action

oral anticoagulants: prolonged therapy

30
Q

what are therapeutic anticoagulants used for?

A
  • DVT
  • PE
  • thromboembolism from atrial fibrillation
  • prosthetic heart valves
  • clotting during kidney dialysis
31
Q

what are therapeutic uses for fibrinolytic agents plus aspirin (antiplatelet)?

A
  • used in therapy of acute myocardial infarction

- former needs to be given within 4-6 hours of onset

32
Q

what are therapeutic uses for aspirin?

A

can reduce risk of occlusive cardiovascular disease in patients already diagnosed as being at risk